skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: Springer Nature OA/Free Journals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis
The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis
Material Type:
Article 		Add to My Research

The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis

BMC musculoskeletal disorders, 2009-06, Vol.10 (1), p.66-66, Article 66 [Peer Reviewed Journal]

Copyright © 2009 Shiraishi et al; licensee BioMed Central Ltd. 2009 Shiraishi et al; licensee BioMed Central Ltd. ;ISSN: 1471-2474 ;EISSN: 1471-2474 ;DOI: 10.1186/1471-2474-10-66 ;PMID: 19527501

Full text available

Citations Cited by
2
Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis
Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis
Material Type:
Article 		Add to My Research

Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis

Calcified tissue international, 2013-08, Vol.93 (2), p.137-146 [Peer Reviewed Journal]

The Author(s) 2013 ;Springer Science+Business Media New York 2013 ;ISSN: 0171-967X ;EISSN: 1432-0827 ;DOI: 10.1007/s00223-013-9734-6 ;PMID: 23644930

Full text available

Citations Cited by
3
24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk
24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk
Material Type:
Article 		Add to My Research

24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk

Advances in therapy, 2017-07, Vol.34 (7), p.1727-1740 [Peer Reviewed Journal]

The Author(s) 2017 ;ISSN: 0741-238X ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-017-0568-x

Digital Resources/Online E-Resources

Citations Cited by
4
Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis
Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis
Material Type:
Article 		Add to My Research

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis

Osteoporosis international, 2015-11, Vol.26 (11), p.2685-2693 [Peer Reviewed Journal]

The Author(s) 2015 ;International Osteoporosis Foundation and National Osteoporosis Foundation 2015 ;ISSN: 0937-941X ;EISSN: 1433-2965 ;DOI: 10.1007/s00198-015-3175-1 ;PMID: 26001561

Full text available

Citations Cited by
5
Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis
Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis
Material Type:
Article 		Add to My Research

Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis

Osteoporosis international, 2012-06, Vol.23 (6), p.1737-1745 [Peer Reviewed Journal]

The Author(s) 2011 ;International Osteoporosis Foundation and National Osteoporosis Foundation 2012 ;ISSN: 0937-941X ;EISSN: 1433-2965 ;DOI: 10.1007/s00198-011-1782-z ;PMID: 21932114

Full text available

Citations Cited by
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait